![](/img/cover-not-exists.png)
A Phase II Study of Efficacy and Safety of a Novel, Oral SHIP1 Activator, AQX-1125, in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Nickel, J. Curtis, Egerdie, Blair, Davis, Edward, Evans, Rober, Mackenzie, Lloyd, Shrewsbury, Stephen B.Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2016.03.003
Date:
March, 2016
File:
PDF, 2.72 MB
english, 2016